About Forward Momentum

This author has not yet filled in any details.
So far Forward Momentum has created 33 blog entries.

Nanostics develops better tests En Route magazine

2022-02-08T23:37:35+00:00

Illustration by Martina Paukova

Full Article
Nanostics develops better tests En Route magazine2022-02-08T23:37:35+00:00

ClarityDX Prostate is one of five top picks for mind-blowing technologies and treatments in 2018

2022-02-08T23:01:45+00:00

Global Edmonton Health reporter Su-Ling Goh highlighted 5 amazing medical technologies and treatments from Edmonton research teams and ClarityDX Prostate was one of them!

Full Article
ClarityDX Prostate is one of five top picks for mind-blowing technologies and treatments in 20182022-02-08T23:01:45+00:00

Edmonton Journal – New lab brings fledgling health tech companies together in shared space

2022-01-04T19:16:16+00:00

A local startup with plans to market a more accurate prostate cancer screening test is one of the first businesses to set up shop in a new downtown shared lab space for health tech companies.

Full Article
Edmonton Journal – New lab brings fledgling health tech companies together in shared space2022-01-04T19:16:16+00:00

Intravital imaging tumor screen used to identify novel metastasis-blocking therapeutic targets

2022-01-04T18:56:47+00:00

This is a micro-review of an original research article from the Lewis research group that identified multiple novel metastasis-blocking targets, by using a whole genome screen and intravital imaging approach, that could be used as therapeutic targets to inhibit solid tumour cell motility.

AUTHOR: KONSTANTIN STOLETOV, LIAN WILLETTS, PERRIN H. BEATTY, AND JOHN D. LEWIS
Full Article
Intravital imaging tumor screen used to identify novel metastasis-blocking therapeutic targets2022-01-04T18:56:47+00:00

BioAlberta Recognizes Alberta Innovators and Entrepreneurs at 2018 Awards Gala

2022-01-04T18:49:17+00:00

CALGARY, Alberta — At its 2018 awards gala, BioAlberta, the province’s life sciences industry association, recognized two leaders for their innovation and achievements. BioAlberta congratulates Circle Cardiovascular Imaging Inc. for winning its Company of the Year award and Dr. John Lewis for winning its Scientific Achievement and Innovation Award.

Full Article
BioAlberta Recognizes Alberta Innovators and Entrepreneurs at 2018 Awards Gala2022-01-04T18:49:17+00:00

FALLING WALLS

2022-01-04T18:48:55+00:00

Dr. John Lewis is the winner of the University of Alberta-TEC Edmonton Falling Walls Venture Competition which earned him entrance to the Falling Walls Finale Competition (the International Conference on Future Breakthroughs in Science and Society) which will be held in Berlin this November. Some travel expenses will be paid for.

Full Article
FALLING WALLS2022-01-04T18:48:55+00:00

A Less Invasive Route to Test For Prostate Cancer

2022-01-04T19:18:04+00:00

Alberta scientists, at Nanostics, have created a blood test that could make a significant impact in the way patients are tested and treated for prostate cancer.

Full Article
A Less Invasive Route to Test For Prostate Cancer2022-01-04T19:18:04+00:00

Funding to develop technology that will detect prostate cancer earlier

2022-02-05T03:17:45+00:00

EDMONTON — Alberta Innovates, the Alberta Cancer Foundation and DynaLIFE have joined together to help commercialize Alberta-owned innovations that will detect cancer earlier and improve treatment for Albertans.

Full Article
Funding to develop technology that will detect prostate cancer earlier2022-02-05T03:17:45+00:00

NVIDIA – How GPU-Powered Cellular Analysis Could Help Avoid Unnecessary Prostate Cancer Biopsies

2022-01-04T19:23:19+00:00

1.3M North American men get biopsies each year checking for prostate cancer, many of them unnecessary. UofA researchers want to change that with a new test that relies on GPU computing.

Full Article
NVIDIA – How GPU-Powered Cellular Analysis Could Help Avoid Unnecessary Prostate Cancer Biopsies2022-01-04T19:23:19+00:00

Startup Nanostics preparing launch of blood-based biomarker test for prostate cancer

2022-01-04T19:25:26+00:00

A new diagnostic will allow men to bypass painful biopsies to test for aggressive prostate cancer.

Full Article
Startup Nanostics preparing launch of blood-based biomarker test for prostate cancer2022-01-04T19:25:26+00:00
Go to Top